DanCann Pharma A/S
DanCann Pharma A/S, a biopharmaceutical company, focuses on discovering, developing, manufacturing, and commercializing therapeutic cannabinoids in various disease areas. It sources, develops, and distributes prescription and over-the-counter cannabinoid-based pharmaceuticals primarily focused on pain patients. The company's development pipeline includes EXT02 CannGros, EXT03 CannGros, EXT04 Cann… Read more
Market Cap & Net Worth: DanCann Pharma A/S (DCPXF)
DanCann Pharma A/S (PINK:DCPXF) has a market capitalization of $39.91 Million ($39.91 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #22296 globally and #7901 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying DanCann Pharma A/S's stock price $10.00 by its total outstanding shares 3991100 (3.99 Million).
DanCann Pharma A/S Market Cap History: 2024 to 2025
DanCann Pharma A/S's market capitalization history from 2024 to 2025. Data shows growth from $39.91K to $39.91 Million (0.00% CAGR).
DanCann Pharma A/S Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how DanCann Pharma A/S's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.01x
DanCann Pharma A/S's market cap is 0.01 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2024 | $39.91K | $7.76 Million | -$7.93 Million | 0.01x | N/A |
Competitor Companies of DCPXF by Market Capitalization
Companies near DanCann Pharma A/S in the global market cap rankings as of March 18, 2026.
Key companies related to DanCann Pharma A/S by market ranking:
- Envirosuite Limited (F:57P): Ranked #22287 globally with a market cap of $39.98 Million USD ( €38.95 Million EUR).
- SCH Group Bhd (KLSE:0161): Ranked #22288 globally with a market cap of $39.97 Million USD ( RM180.05 Million MYR).
- Clipper Realty Inc (NYSE:CLPR): Ranked #22297 globally with a market cap of $39.85 Million USD.
- Black Mammoth Metals Corporation (PINK:LQRCF): Ranked #22298 globally with a market cap of $39.81 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #22287 | Envirosuite Limited | F:57P | $39.98 Million | €0.04 |
| #22288 | SCH Group Bhd | KLSE:0161 | $39.97 Million | RM0.31 |
| #22297 | Clipper Realty Inc | NYSE:CLPR | $39.85 Million | $3.07 |
| #22298 | Black Mammoth Metals Corporation | PINK:LQRCF | $39.81 Million | $1.30 |
DanCann Pharma A/S Historical Marketcap From 2024 to 2025
Between 2024 and today, DanCann Pharma A/S's market cap moved from $39.91K to $ 39.91 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $39.91 Million | +99900.00% |
| 2024 | $39.91K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of DanCann Pharma A/S was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $39.91 Million USD |
| MoneyControl | $39.91 Million USD |
| MarketWatch | $39.91 Million USD |
| marketcap.company | $39.91 Million USD |
| Reuters | $39.91 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.